Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • NEWS

Japan’s approval of stem-cell treatment for spinal-cord injury concerns scientists

Chief among their worries is insufficient evidence that the therapy works.
  1. David Cyranoski

    1. David Cyranoski reports for Nature from Shanghai, China.

    View author publications

    You can also search for this author in PubMed  Google Scholar

Japan has approved a stem-cell treatment for spinal-cord injuries. The event marks the first such therapy for this kind of injury to receive government approval for sale to patients.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Nature 565, 544-545 (2019)

doi: https://doi.org/10.1038/d41586-019-00178-x

References

  1. Inoue, M. et al. Glia 44, 111-118 (2003).

    Article  PubMed  Google Scholar 

  2. Kim, S. et al. Brain Res. 1123, 27–33 (2006).

    Article  PubMed  Google Scholar 

  3. Akiyama, Y. et al. Glia 39, 229-236, (2002).

    Article  PubMed  Google Scholar 

Download references

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Advanced search

Quick links